戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 l practice represents an exciting advance in respiratory medicine.
2 ction among subjects not taking prescription respiratory medicine.
3  to studying oxygen sensing and signaling in respiratory medicine.
4  industry parties interested in personalized respiratory medicine.
5 ntary and alternative medicines (14.5 %) and respiratory medicines (0 %).
6  carefully selected by leading international respiratory medicine and infectious diseases societies (
7 ass analysis in the fields of critical care, respiratory medicine, and beyond.
8  by subject category: all internal medicine, respiratory medicine, and toxicology journals studied ha
9       They were referred from the outpatient respiratory medicine clinic of the hospital.
10 rine, gastroenterological, neurological, and respiratory medicine clinics in secondary care.
11                                   The Lancet Respiratory Medicine Commission on drug-resistant tuberc
12                                   The Lancet Respiratory Medicine Commission on the future of cystic
13                             A need exists in respiratory medicine for a technology capable of identif
14 rolled on the trial at the Oxford Centre for Respiratory Medicine (Oxford, UK).
15  to start on systemic corticosteroids by the respiratory medicine physician on duty.
16  access service integrating palliative care, respiratory medicine, physiotherapy, and occupational th
17 nterdisciplinary approach, bringing together respiratory medicine, rehabilitation sciences, social sc
18 nt types from 52 isolates collected from the respiratory medicine unit and elsewhere in Australia.
19  patients with cystic fibrosis attending our respiratory medicine unit have had Scedosporium organism
20 ated from more than one source: one from two respiratory medicine unit inpatients and one from two ep
21    A single common type was isolated from 11 respiratory medicine unit inpatients.
22 f isolates with a single typing pattern from respiratory medicine unit patients may suggest transmiss
23  among active asthmatics taking prescription respiratory medicine, whereas lung function in other act